pharmaphorum November 24, 2021

Patient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn Lobban and Sarah Avent discuss the need to engage with patients at every level for holistic inclusion of the patient voice in order for pharma to become truly patient-centric.

The Covid pandemic has sparked people’s interest in science and medicine and empowered the public to make important health choices. It’s also shone a light on the need to provide accurate and timely information and to engage the public at every point in the medicine development lifecycle.

More than anything, however, it highlights the importance of patient-engagement more generally in medicine development, a concept the pharmaceutical industry has been talking about for years....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma, Pharma / Biotech
What the Medicaid unwinding means for plans, providers, and more
EMTALA and abortion restrictions: Inside the Supreme Court case
Expanding Access to Telehealth for Medication Abortion Care in a Constrained Policy Environment
FDA launches initiative to advance home healthcare models, devices
HHS releases national suicide prevention strategy, plan

Share This Article